Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.

Arthritis and rheumatism

Volumn 64, Issue 4, 2012, Pages 1263-1271

  Beukelman, Timothy ^a   Haynes, Kevin ^b   Curtis, Jeffrey R ^b   Xie, Fenglong ^b   Chen, Lang ^b   Bemrich Stolz, Christina J ^b   Delzell, Elizabeth ^b   Saag, Kenneth G ^b   Solomon, Daniel H ^b   Lewis, James D ^b   Safety Assessment of Biological Therapeutics Collaboration, ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; DRUG ANTAGONISM; FEMALE; HUMAN; INCIDENCE; JUVENILE RHEUMATOID ARTHRITIS; MALE; NEOPLASM; PREVALENCE;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; METHOTREXATE; NEOPLASMS; PREVALENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866175338     PISSN: None     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34348     Document Type: Article

References (0)